MCR 313 (Lamivudine 150 mg)
Pill with imprint MCR 313 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Appco Pharma LLC.
Lamivudine is used in the treatment of nonoccupational exposure; hepatitis b; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MCR 313
Lamivudine
- Imprint:
- MCR 313
- Strength:
- 150 mg
- Color:
- White
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Appco Pharma LLC
- National Drug Code (NDC):
- 55801-0313
More about lamivudine
- Lamivudine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
Other brands: Epivir, Epivir-HBV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
